Knowledge-based planning models for radiation therapy across multiple cancer sites produced fully automated, consistent, high ...

Researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...

Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer offers better perioperative outcomes.

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...

Most people don’t think about their bladder very often. But as you get older, it’s something that requires a little but more ...

Here the authors report the design and characterization of a biodegradable urease-powered nanomotor containing STING agonist, promoting anti-tumor immune responses in bladder cancer models.

Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...

Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria ...